EUVIMEDEUVIMED entdecken
Crossref

Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer

Yosuke Sugiyama iD, Yoshihiko Tasaki iD, Yoshihisa Mimura, Taku Naiki iD, Kunihiro Odagiri, Tomoya Kataoka, Toshiki Etani, Moeko Iida iD, Takaaki Hasegawa iD, Yosuke Furukawa, Takahiro Yasui, Tatsuo Akechi iD und 1 weitere

Japanese Journal of Clinical Oncology · 2026

DOI: 10.1093/jjco/hyaf210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Clinical Oncology, 2026. Verfasst von Yosuke Sugiyama und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Nagoya City University Hospital, Nagoya 467-8601, Japan. Hauptthemen laut MEDLINE: Oxycodone, Analgesics, Opioid, Pain Measurement, Cancer Pain. Die Arbeit nennt 30 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Kobayashi Foundation for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While opioid analgesics are widely used to manage moderate-to-severe cancer-related pain, dosing is mostly based on subjective pain reports rather than objective physiological indicators, potentially contributing to inconsistent dosing and suboptimal pain control. This study investigated whether model-predicted oxycodone serum concentrations could guide opioid dosing and whether wearable-derived heart rate and step count, combined with these predictions, could complement conventional numerical rating scale (NRS) pain assessments.

Methods

Sixteen patients with advanced genitourinary cancer receiving oxycodone were prospectively monitored. Clinically collected serum concentrations were used to simulate individual pharmacokinetic profiles. Pain intensity was assessed using the NRS, and physiological parameters were recorded using wearable devices. Linear mixed-effects models were constructed to evaluate the associations between simulated serum oxycodone concentrations, NRS, and physiological variables.

Results

In the linear mixed-effects model, simulated serum oxycodone concentrations were significantly associated with lower NRS scores (β = −0.26, P = .0177). Although neither heart rate nor step count independently predicted NRS, incorporating heart rate into the model improved the overall fit. Thus, heart rate may capture pain-related physiological responses not fully explained by oxycodone concentration alone, thereby enhancing the explanatory power of the model.

Conclusions

Model-based simulated serum oxycodone concentrations may serve as an objective reference for individualized pain assessment and opioid titration. Combining wearable-derived physiological signals, particularly heart rate, with model-predicted oxycodone concentrations may further improve the precision and adaptability of pain management in palliative care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxycodoneAnalgesics, OpioidPain MeasurementCancer PainWearable Electronic DevicesHumansMaleMiddle AgedAgedFemaleProspective StudiesHeart Rate

Stichwörter der Autor:innen

cancer-related painopioid analgesicspain assessmentpain managementpalliative care

Substanzen

OxycodoneAnalgesics, Opioid

Autor:innen und Institutionen

  • Department of Pharmacy, Nagoya City University Hospital, Nagoya 467-8601, Japan.
  • Department of Clinical Pharmaceutics, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467-8601, Japan.
  • Center for Psycho-oncology and Palliative Care, Nagoya City University Hospital, Nagoya, 467-8601, Japan.
  • Department of Nephro-urology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, 467-8601, Japan.
  • Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Chiba Institute of Science, Chiba, 288-0025, Japan.
  • Department of Psychiatry, Graduate School of Medical Sciences and Medical School, Nagoya City University, Nagoya, 467-8601, Japan.

ORCID-Profile: Yosuke Sugiyama, Yoshihiko Tasaki, Taku Naiki, Moeko Iida, Takaaki Hasegawa, Tatsuo Akechi

Förderung

  • Japan Society for the Promotion of Science
  • Kobayashi Foundation for Cancer Research

Zitieren

APA

Sugiyama, Y., Tasaki, Y., Mimura, Y., Naiki, T., Odagiri, K., Kataoka, T., Etani, T., Iida, M., Hasegawa, T., Furukawa, Y., Yasui, T., Akechi, T., & Furukawa-Hibi, Y. (2026). Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf210

Vancouver

Sugiyama Y, Tasaki Y, Mimura Y, Naiki T, Odagiri K, Kataoka T, et al. Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer. Japanese Journal of Clinical Oncology. 2026. doi:10.1093/jjco/hyaf210

BibTeX
@article{Sugiyama2026,
  author = {Sugiyama, Yosuke and Tasaki, Yoshihiko and Mimura, Yoshihisa and Naiki, Taku and Odagiri, Kunihiro and Kataoka, Tomoya and Etani, Toshiki and Iida, Moeko and Hasegawa, Takaaki and Furukawa, Yosuke and Yasui, Takahiro and Akechi, Tatsuo and Furukawa-Hibi, Yoko},
  title = {Integrating pharmacokinetic modeling and wearable-derived physiological data to assess pain intensity in patients with advanced urologic cancer},
  journal = {Japanese Journal of Clinical Oncology},
  year = {2026},
  doi = {10.1093/jjco/hyaf210}
}
Kostenlos starten →